Profile
Richard A. F.
Dixon is the founder of 7 Hills Pharma LLC.
Prior to founding 7 Hills Pharma LLC, he worked as the Chief Scientific Officer & SVP-Research at Encysive Pharmaceuticals, Inc. from 1990 to 2011.
Before that, he was the Director & Head-Molecular Biology at Merck Sharp & Dohme Research Laboratories from 1988 to 1990.
Dixon received his undergraduate degree from Texas A&M University and his doctorate from Baylor College of Medicine.
Richard A. F. Dixon active positions
| Companies | Position | Start |
|---|---|---|
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Founder | - |
Former positions of Richard A. F. Dixon
| Companies | Position | End |
|---|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Chief Tech/Sci/R&D Officer | 29/04/2011 |
Merck Sharp & Dohme Research Laboratories | Director/Board Member | 01/01/1990 |
Training of Richard A. F. Dixon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme Research Laboratories | |
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Richard A. F. Dixon
















